CL2015002114A1 - Method for the treatment of pain through the intervention of spinal panexins - Google Patents

Method for the treatment of pain through the intervention of spinal panexins

Info

Publication number
CL2015002114A1
CL2015002114A1 CL2015002114A CL2015002114A CL2015002114A1 CL 2015002114 A1 CL2015002114 A1 CL 2015002114A1 CL 2015002114 A CL2015002114 A CL 2015002114A CL 2015002114 A CL2015002114 A CL 2015002114A CL 2015002114 A1 CL2015002114 A1 CL 2015002114A1
Authority
CL
Chile
Prior art keywords
pain
treatment
panexins
spinal
intervention
Prior art date
Application number
CL2015002114A
Other languages
Spanish (es)
Inventor
Serrano Teresa Pelissier
Córdova Luis Constandil
Kunstmann Alejandro Hernández
López David Bravo
Original Assignee
Univ Santiago Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Santiago Chile filed Critical Univ Santiago Chile
Priority to CL2015002114A priority Critical patent/CL2015002114A1/en
Publication of CL2015002114A1 publication Critical patent/CL2015002114A1/en
Priority to PCT/CL2016/050042 priority patent/WO2017015774A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Abstract

METODO DE TRATAMIENTO DE DOLOR EN MAMIFEROS QUE COMPRENDE ADMINISTRAR UN COMPUESTO INHIBIDOR DE LA FUNCION DE PANEXINA QUE ES SELECCIONADO DE CARBENOXOLONA, PROBENECID, 10PANX, ACIDO FLUFENAMICO O MEFLOQUINA; Y EL USO DE UN COMPUESTO INHIBIDOR DE LA FUNCION DE PANEXINA UTIL PARA EL TRATAMIENTO DEL DOLORMETHOD OF TREATMENT OF PAIN IN MAMMALS THAT IT INCLUDES TO ADMINISTER AN INHIBITING COMPOUND OF THE PANEXINE FUNCTION THAT IS SELECTED FROM CARBENOXOLONE, PROBENECID, 10PANX, FLUFENAMIC ACID OR MEFLOCHINE; AND THE USE OF AN INHIBITOR COMPOUND OF THE FUNCTION OF PANEXIN USEFUL FOR THE TREATMENT OF PAIN

CL2015002114A 2015-07-29 2015-07-29 Method for the treatment of pain through the intervention of spinal panexins CL2015002114A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2015002114A CL2015002114A1 (en) 2015-07-29 2015-07-29 Method for the treatment of pain through the intervention of spinal panexins
PCT/CL2016/050042 WO2017015774A1 (en) 2015-07-29 2016-07-29 Pain treatment method involving the use of spinal pannexins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2015002114A CL2015002114A1 (en) 2015-07-29 2015-07-29 Method for the treatment of pain through the intervention of spinal panexins

Publications (1)

Publication Number Publication Date
CL2015002114A1 true CL2015002114A1 (en) 2016-05-06

Family

ID=56081016

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015002114A CL2015002114A1 (en) 2015-07-29 2015-07-29 Method for the treatment of pain through the intervention of spinal panexins

Country Status (2)

Country Link
CL (1) CL2015002114A1 (en)
WO (1) WO2017015774A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114712368A (en) * 2022-05-06 2022-07-08 延安大学 Application of leiclopride and carbenoxolone in preparation of pain medicine

Also Published As

Publication number Publication date
WO2017015774A1 (en) 2017-02-02

Similar Documents

Publication Publication Date Title
CL2018000685A1 (en) New bicyclic compounds as dual atx / ca inhibitors
CL2017001459A1 (en) Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
CL2018000687A1 (en) New bicyclic compounds as atx inhibitors.
UY37036A (en) INHIBITING COMPOUNDS OF THE QUINASA DE UNIÓN A TANK
CL2017001046A1 (en) Bromodomain Inhibitors
CL2017000576A1 (en) Mk2 inhibitors and their uses
EA201692316A1 (en) DERIVATIVES OF HOLAN FOR APPLICATION IN THE TREATMENT AND / OR PREVENTION OF FXR AND TGR5 / GPBAR1-MEDIATED DISEASES
BR112016018555A8 (en) CYCLOPROPYLAMINES AS LSD1 INHIBITORS, THEIR USE, PHARMACEUTICAL COMPOSITION INCLUDING THEM AND LSD1 INHIBITION METHOD
EA201691259A1 (en) REGULATORS Nrf2
EA201600589A1 (en) DIACYlGLYCERINACYLTRANSFERASE 2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC AND METABOLISM-CONNECTED DISORDERS
BR112017001789A2 (en) compositions and methods of use for treating metabolic disorders
UY37018A (en) PAD4 BICYCLIC INHIBITORS
EA201792496A1 (en) METHODS OF TREATMENT OF INFLAMMATION OR NEUROPATHIC PAIN
CL2016000326A1 (en) Compositions and method to treat conditions associated with the complement
EA201890331A1 (en) PYRIDINODICARBOXAMIDES FOR APPLICATION AS BROMODOUM INHIBITORS AS
GT201600027A (en) RORC2 INHIBITORS AND THEIR METHODS OF USE
EA201690844A1 (en) GSK-3 INHIBITORS
DOP2016000120A (en) NEW DGAT2 INHIBITORS
CL2018000611A1 (en) Salts of a pim kinase inhibitor
ECSP19057403A (en) THERAPEUTIC USES OF AN INSECT POWDER
EA201891347A1 (en) Aza-benzimidazole inhibitors PAD4
CO2018002440A2 (en) Useful compounds to inhibit ror-gamma-t
EA201790484A1 (en) Derivatives of tetrahydroquinoline as bromodomain inhibitors
BR112017028448A2 (en) ado-resistant cysteamine analogs and uses thereof
DK3515894T3 (en) INDAZOLE COMPOUNDS FOR USE OF T tendon and / or ligament injuries